UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~November~~September 211, ~~2022~~2023

NANO MOBILE HEALTHCARE, INC.

(Exact Name of Registrant as Specified in its Charter)

Nevada
(State or other jurisdiction
of incorporation)

000-55155
(Commission
File Number)

98-0659770
(I.R.S. Employer
Identification No.)

370 Ampola Ave., Suite 200-A
Torrance, CA 90501
(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code: (424) 358-1046

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Common Stock, par value of $0.00001

VNTH

OTCMKTS

Item 41.01. ~~Changes~~Entry inInto ~~Registrant’s~~a ~~Certifying~~Material ~~Accountant~~Definitive Agreement.

On ~~November~~September 211, ~~2022 the Registrant engaged Haroon Imtiaz~~2023, ~~CPA as~~ the ~~Registrant's~~Company ~~new~~and ~~independent~~its ~~registered~~control ~~public~~shareholder ~~accounting~~entered ~~firm.~~into ~~The appointment~~an ofagreement ~~Haroon~~to ~~Imtiaz,~~cancel ~~CPA was approved by~~ the ~~Board~~September ~~of Directors of Nano Mobile Healthcare~~15, ~~Inc..~~2022 ~~Haroon~~Securities ~~Imtiaz, CPAwill be reviewing~~Purchase ~~and~~Agreement ~~providing~~through ~~audit~~which ~~services~~all ~~related to~~ the ~~financial~~outstanding ~~statements~~shares ~~that~~of ~~are to be included in~~ the ~~Annual~~control ~~Report~~voting ~~for~~block ~~the~~Preferred ~~period~~stock ~~ended~~was ~~December 31,~~sold ~~2021. Haroon Imtiaz, CPA did not prepare or provide any financial reports for any periods prior~~ to ~~the~~Mr. ~~date~~Adam ofMatruski ~~engagement,~~an ~~nor~~EV ~~did~~Charge-stations ~~it prepare or provide any financial reports for, or prior to the year ended December 31, 2021~~entrepreneur. ~~Neither~~Following the ~~Company,~~execution ~~nor any person on behalf~~ of ~~the~~this ~~Company,~~cancellation ~~consulted with Haroon Imtiaz~~agreement, ~~CPA during~~ the ~~Company's~~control ~~two~~of ~~most recent fiscal years or~~ the ~~subsequent~~company ~~interim period~~reverts ~~prior~~back to ~~the~~Alpharidge ~~engagement of Haroon Imtiaz~~Capital, ~~CPA~~ LLC.

Item 95.~~01. Financial~~02 ~~Statements~~Departure ~~and~~of ~~Exhibits~~Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

On September 11, 2023, Mr. Adam Matruski resigned from the positions of the President and CEO, Director, Secretary, and Treasurer of the Company. Mr. Matruski’s resignation followed the cancellation of the sale of the shares of control (dvoting block) ~~Exhibits~~Preferred stock of the Company which was sold to Mr. Matruski on September 15, 2022.

~~Exhibit~~On NoSeptember 11, 2023, following Mr. Matruski’s resignation pursuant to the cancellation agreement, the Company appointed Mr. Roy Watson as its President and CEO, effectively immediately.

~~10.1~~Item ~~Audit~~9.01. Financial ~~Report~~Statements and Exhibits.

~~SIGNATURE~~(d) Exhibits

~~Pursuant~~Exhibit ~~to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized~~No.

~~NANO MOBILE~~10.1 ~~HEALTHCARE,~~Securities ~~INC.~~Purchase Agreement

Date: December 1, 2022	By: /s/ Adam Matruski
	Name:	Adam Matruski
	Title:	Chairman, President and CEO

10.2 Board Resolution for the resignation, and appointment of Officers

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NANO MOBILE HEALTHCARE, INC.

Date: September 13, 2023	By: /s/ Roy Watson
	Name:	Roy Watson
	Title:	Chairman, President and CEO

Filing Compare · Nano Mobile Healthcare, Inc.